White matter hyperintensity volume and cerebral perfusion in older individuals with hypertension using arterial spin-labeling

American Journal of Neuroradiology

Volumn 37, Issue 10, 2016, Pages 1824-1830

  Van Dalen, J W ^a   Mutsaerts, H J M M ^b   Nederveen, A J ^b   Vrenken, H ^c,d   Steenwijk, M D ^c   Caan, M W A ^b   Majoie, C B L M ^b   Van Gool, W A ^a   Richard, E ^a,e  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Departments of Radiology and Nuclear Medicine   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ATT=arterial transit time; NAWM=normal appearing white matter; PreDiVA M=MRI substudy of the preDiVA trial; PreDiVA=Prevention of Dementia by Intensive Vascular Care trial; WMH=white matter hyperintensity; =standardized

Indexed keywords

AGED; ARTERIAL SPIN LABELING; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN SIZE; COMPARATIVE STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; RADIOLOGICAL PARAMETERS; SENSITIVITY ANALYSIS; SYSTOLIC HYPERTENSION; WHITE MATTER; WHITE MATTER HYPERINTENSITY VOLUME;

EID: 84990849854     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A4828     Document Type: Article

References (48)

1. Schmidt R, Schmidt H, Haybaeck J, et al. Heterogeneity in age-related white matter changes. Acta Neuropathol 2011;122: 171-85 CrossRef Medline
2. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341: c3666 CrossRef Medline
3. Schmahmann JD, Smith EE, Eichler FS, et al. Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates. Ann N Y Acad Sci 2008;1142: 266-309 CrossRef Medline
4. Moran C, Phan TG, Srikanth VK. Cerebral small vessel disease: a review of clinical, radiological, and histopathological phenotypes. Int J Stroke 2012;7: 36-46 CrossRef Medline
5. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9: 689-701 CrossRef Medline
6. Brown WR, Thore CR. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 2011; 37: 56-74 CrossRef Medline
7. Bastos-Leite AJ, Kuijer JP, Rombouts SA, et al. Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. AJNR Am J Neuroradiol 2008;29: 1296-301 CrossRef Medline
8. Markus HS. Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. J Neurol Neurosurg Psychiatry 2000; 69: 48-53 CrossRef Medline
9. O'Sullivan M, Lythgoe DJ, Pereira AC, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 2002;59: 321-26 CrossRef Medline
10. Brickman AM, Zahra A, Muraskin J, et al. Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res 2009;172: 117-20 CrossRef Medline
11. Zhang Q, Stafford RB, Wang Z, et al. Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease. J Alzheimers Dis 2012;32: 677-87 CrossRef Medline
12. Marstrand JR, Garde E, Rostrup E, et al. Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke 2002;33: 972-76 CrossRef Medline
13. Sachdev P, Wen W, Shnier R, et al. Cerebral blood volume in T2-weighted white matter hyperintensities using exogenous contrast based perfusion MRI. J Neuropsychiatry Clin Neurosci 2004;16: 83-92 Medline
14. Makedonov I, Black SE, MacIntosh BJ. Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT. Eur J Neurol 2013;20: 243-50 CrossRef Medline
15. Benedictus MR, Binnewijzend MA, Kuijer JP, et al. Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer's disease. Neurobiol Aging 2014;35: 2665-70 CrossRef Medline
16. Crane DE, Black SE, Ganda A, et al. Gray matter blood flow and volume are reduced in association with white matter hyperintensity lesion burden: a cross-sectionalMRIstudy. Front Aging Neurosci 2015;7: 131 CrossRef Medline
17. Tzourio C, Lévy C, Dufouil C, et al. Low cerebral blood flow velocity and risk of white matter hyperintensities. Ann Neurol 2001;49: 411-14 CrossRef Medline
18. Novak V, Last D, Alsop DC, et al. Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care 2006;29: 1529-34 CrossRef Medline
19. Heliopoulos I, Artemis D, Vadikolias K, et al. Association of ultrasonographic parameters with subclinical white-matter hyperintensities in hypertensive patients. Cardiovasc Psychiatry Neurol 2012; 2012: 1-8 CrossRef Medline
20. Alosco ML, Brickman AM, Spitznagel MB, et al. Independent and interactive effects of blood pressure and cardiac function on brain volume and white matter hyperintensities in heart failure. J AmSoc Hypertens 2013;7: 336-43 CrossRef Medline
21. Holland CM, Smith EE, Csapo I, et al. Spatial distribution of whitematter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke 2008;39: 1127-33 CrossRef Medline
22. TenDamVH, van den Heuvel DM, de Craen AJ, et al. Decline in total cerebral blood flow is linked with increase in periventricular but not deep white matter hyperintensities. Radiology 2007;243: 198-203 CrossRef Medline
23. Promjunyakul N, Lahna D, Kaye JA, et al. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures. Neuroimage Clin 2015;8: 224-29 CrossRef Medline
24. Richard E, Van den Heuvel E, Moll van Charante EP, et al. Prevention of dementia by intensive vascular care (PreDiVA): a cluster-randomized trial in progress. Alzheimer Dis Assoc Disord 2009;23: 198-204 CrossRef Medline
25. Alsop DC, Dai W, Grossman M, et al. Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. J Alzheimers Dis 2010;20: 871-80 CrossRef Medline
26. Steenwijk MD, Pouwels PJ, Daams M, et al. Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs). Neuroimage Clin 2013;3: 462-69 CrossRef Medline
27. Mutsaerts HJ, van Dalen JW, Heijtel DF, et al. Cerebral perfusion measurements in elderly with hypertension using arterial spin labeling. PLoS One 2015;10: e0133717 CrossRef Medline
28. Wang J, Alsop DC, Song HK, et al. Arterial transit time imaging with flow encoding arterial spin tagging (FEAST). Magn Reson Med 2003; 50: 599-607 CrossRef Medline
29. Buxton RB, Frank LR, Wong EC, et al. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998;40: 383-96 CrossRef Medline
30. Jenkinson M, Beckmann CF, Behrens TE, et al. FSL. Neuroimage 2012;62: 782-90 CrossRef Medline
31. Gouw AA, Seewann A, van der Flier WM, et al. Heterogeneity of small vessel disease: a systematic review ofMRIand histopathology correlations. J Neurol Neurosurg Psychiatry 2011;82: 126-35 CrossRef Medline
32. Yang Y, Engelien W, Xu S, et al. Transit time, trailing time, and cerebral blood flow during brain activation: measurement using multislice, pulsed spin-labeling perfusion imaging. Magn Reson Med 2000;44: 680-85 Medline
33. Wen W, Sachdev P, Shnier R, et al. Effect of white matter hyperintensities on cortical cerebral blood volume using perfusion MRI. Neuroimage 2004;21: 1350-56 CrossRef Medline
34. Conklin J, Silver FL, Mikulis DJ, et al. Are acute infarcts the cause of leukoaraiosis? Brain mapping for 16 consecutive weeks. Ann Neurol 2014;76: 899-904 CrossRef Medline
35. Qureshi AI, Caplan LR. Intracranial atherosclerosis. Lancet 2014; 383: 984-98 CrossRef Medline
36. Benedictus MR, Goos JD, Binnewijzend MA, et al. Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease. Neurobiol Aging 2013;34: 2488-94 CrossRef Medline
37. de la Torre JC. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. J Alzheimers Dis 2012;32: 553-67 CrossRef Medline
38. Macintosh BJ, Marquardt L, Schulz UG, et al. Hemodynamic alterations in vertebrobasilar large artery disease assessed by arterial spin-labeling MR imaging. AJNR Am J Neuroradiol 2012;33: 1939-44 CrossRef Medline
39. Tryambake D, He J, Firbank MJ, et al. Intensive blood pressure lowering increases cerebral blood flow in older subjects with hypertension. Hypertension 2013;61: 1309-15 CrossRef Medline
40. Muller M, van der Graaf Y, Visseren FL, et al. Blood pressure, cerebral blood flow, and brain volumes: theSMART-MRstudy. J Hypertens 2010;28: 1498-505 CrossRef Medline
41. The Netherlands National Institute for Health and the Environment (RIVM) blood pressure statistics (Dutch). https: //www. volksgezond heidenzorg. info/onderwerp/bloeddruk/cijfers-context/huidige-situatie#! node-verhoogde-bloeddruk-naar-leeftijd. Accessed November 26, 2015
42. van Gelderen P, de Zwart JA, Duyn JH. Pittfalls ofMRImeasurement of white matter perfusion based on arterial spin labeling. Magn Reson Med 2008;59: 788-95 CrossRef Medline
43. Petersen ET, Zimine I, Ho YC, et al. Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques. Br J Radiol 2006;79: 688-701 CrossRef Medline
44. Mutsaerts HJ, Richard E, Heijtel DF, et al. Gray matter contamination in arterial spin labeling white matter perfusion measurements in patients with dementia. Neuroimage Clin 2014;4: 139-44 CrossRef Medline
45. Wu WC, Lin SC, Wang DJ, et al. Measurement of cerebral white matter perfusion using pseudocontinuous arterial spin labeling 3T magnetic resonance imaging: an experimental and theoretical investigation of feasibility. PLoS One 2013;8: e82679 CrossRef Medline
46. van Osch MJ, TeeuwisseWM,van Walderveen MA, et al. Can arterial spin labeling detect white matter perfusion signal? Magn Reson Med 2009;62: 165-73 CrossRef Medline
47. Brickman AM, Guzman VA, Gonzalez-Castellon M, et al. Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated. Neurosci Lett 2015;592: 54-58 CrossRef Medline
48. Birns J, Jarosz J, Markus HS, et al. Cerebrovascular reactivity and dynamic autoregulation in ischaemic subcortical white matter disease. J Neurol Neurosurg Psychiatry 2009;80: 1093-98 CrossRef Medline